{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T11:42:13Z","timestamp":1779190933979,"version":"3.51.4"},"reference-count":12,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T00:00:00Z","timestamp":1716768000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["worldallergyorganizationjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Allergy Organization Journal"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.waojou.2024.100923","type":"journal-article","created":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T19:54:44Z","timestamp":1720122884000},"page":"100923","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Real-life management of atopic dermatitis patients with an inadequate response to on-label use of dupilumab"],"prefix":"10.1016","volume":"17","author":[{"given":"R\u00e9mi","family":"Strizzolo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Seneschal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ang\u00e8le","family":"Soria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delphine","family":"Staumont-Sall\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9bastien","family":"Barbarot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuelle","family":"Viguier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Jachiet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey","family":"Nosbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aude","family":"Cl\u00e9ment","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Tauber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phanie","family":"Mallet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1508-1977","authenticated-orcid":false,"given":"Aur\u00e9lie","family":"Du-Thanh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.waojou.2024.100923_bib1","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1016\/S0140-6736(17)31191-1","article-title":"Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial","volume":"389","author":"Blauvelt","year":"2017","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.waojou.2024.100923_bib2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jaad.2019.02.053","article-title":"Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort","volume":"81","author":"Faiz","year":"2019","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.waojou.2024.100923_bib3","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1159\/000512890","article-title":"Successful combination of systemic agents for the treatment of atopic dermatitis resistant to dupilumab therapy","volume":"237","author":"Gori","year":"2021","journal-title":"Dermatol Basel Switz"},{"key":"10.1016\/j.waojou.2024.100923_bib4","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/bjd.21776","article-title":"Dupilumab with concomitant Janus kinase inhibitor: a novel treatment strategy for atopic dermatitis with poor response to dupilumab","volume":"187","author":"Yang","year":"2022","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.waojou.2024.100923_bib5","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s40257-019-00436-8","article-title":"Management recommendations for dupilumab partial and non-durable responders in atopic dermatitis","volume":"20","author":"Hendricks","year":"2019","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.waojou.2024.100923_bib6","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jaad.2021.06.017","article-title":"Management of inadequate response and adverse effects to dupilumab in atopic dermatitis","volume":"86","author":"Narla","year":"2022","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.waojou.2024.100923_bib8","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/jdv.14880","article-title":"Drug survival and postdrug survival of first-line immunosuppressive treatments for atopic dermatitis: comparison between methotrexate and cyclosporine","volume":"32","author":"Law Ping Man","year":"2018","journal-title":"J\u00a0Eur Acad Dermatol Venereol JEADV"},{"key":"10.1016\/j.waojou.2024.100923_bib9","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.jaip.2017.07.007","article-title":"Methotrexate versus cyclosporine in adults with moderate-to-severe atopic dermatitis: a phase III randomized noninferiority trial","volume":"6","author":"Goujon","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.waojou.2024.100923_bib10","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1001\/jamadermatol.2019.2613","article-title":"Development or exacerbation of head and neck dermatitis in patients treated for atopic dermatitis with dupilumab","volume":"155","author":"Soria","year":"2019","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.waojou.2024.100923_bib11","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jaad.2022.05.021","article-title":"Dupilumab-associated head and neck dermatitis resolves temporarily with itraconazole therapy and rapidly with transition to upadacitinib, with Malassezia-specific immunoglobulin E levels mirroring clinical response","volume":"88","author":"Kozera","year":"2023","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.waojou.2024.100923_bib13","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jdcr.2021.01.020","article-title":"Remission of severe atopic dermatitis with dupilumab and rescue tofacitinib therapy","volume":"10","author":"Peterson","year":"2021","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.waojou.2024.100923_bib12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1001\/jamadermatol.2019.3617","article-title":"Efficacy and safety of multiple dupilumab dose regimens after initial successful treatment in patients with atopic dermatitis: a randomized clinical trial","volume":"156","author":"Worm","year":"2020","journal-title":"JAMA Dermatol"}],"container-title":["World Allergy Organization Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455124000541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455124000541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T11:22:13Z","timestamp":1724844133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1939455124000541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":12,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1939455124000541"],"URL":"https:\/\/doi.org\/10.1016\/j.waojou.2024.100923","relation":{},"ISSN":["1939-4551"],"issn-type":[{"value":"1939-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-life management of atopic dermatitis patients with an inadequate response to on-label use of dupilumab","name":"articletitle","label":"Article Title"},{"value":"World Allergy Organization Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.waojou.2024.100923","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of World Allergy Organization.","name":"copyright","label":"Copyright"}],"article-number":"100923"}}